FDN-154304/CIHR/Canada[Grants and Funding] - Search Results

Year	Number of Results
2018	3
2019	6
2020	4
2021	4
2022	4
2024	0

1

Taking regulatory T-cell therapy one step further.

Sicard A, Boardman DA, Levings MK. Sicard A, et al. Curr Opin Organ Transplant. 2018 Oct;23(5):509-515. doi: 10.1097/MOT.0000000000000566. Curr Opin Organ Transplant. 2018. PMID: 30063480 Review.

2

Guiding regulatory T cells to the allograft.

Lamarche C, Levings MK. Lamarche C, et al. Curr Opin Organ Transplant. 2018 Feb;23(1):106-113. doi: 10.1097/MOT.0000000000000483. Curr Opin Organ Transplant. 2018. PMID: 29140829 Review.

3

Emerging strategies for treating autoimmune disorders with genetically modified Treg cells.

Boardman DA, Levings MK. Boardman DA, et al. J Allergy Clin Immunol. 2022 Jan;149(1):1-11. doi: 10.1016/j.jaci.2021.11.007. J Allergy Clin Immunol. 2022. PMID: 34998473 Review.

4

Methods to manufacture regulatory T cells for cell therapy.

MacDonald KN, Piret JM, Levings MK. MacDonald KN, et al. Clin Exp Immunol. 2019 Jul;197(1):52-63. doi: 10.1111/cei.13297. Epub 2019 Apr 15. Clin Exp Immunol. 2019. PMID: 30913302 Free PMC article. Review.

5

Building a CAR-Treg: Going from the basic to the luxury model.

Rosado-Sánchez I, Levings MK. Rosado-Sánchez I, et al. Cell Immunol. 2020 Dec;358:104220. doi: 10.1016/j.cellimm.2020.104220. Epub 2020 Sep 28. Cell Immunol. 2020. PMID: 33096321 Review.

6

Helios is a marker, not a driver, of human Treg stability.

Lam AJ, Uday P, Gillies JK, Levings MK. Lam AJ, et al. Eur J Immunol. 2022 Jan;52(1):75-84. doi: 10.1002/eji.202149318. Epub 2021 Oct 13. Eur J Immunol. 2022. PMID: 34561855 Free article.

7

Suppressive and Gut-Reparative Functions of Human Type 1 T Regulatory Cells.

Cook L, Stahl M, Han X, Nazli A, MacDonald KN, Wong MQ, Tsai K, Dizzell S, Jacobson K, Bressler B, Kaushic C, Vallance BA, Steiner TS, Levings MK. Cook L, et al. Gastroenterology. 2019 Dec;157(6):1584-1598. doi: 10.1053/j.gastro.2019.09.002. Epub 2019 Sep 10. Gastroenterology. 2019. PMID: 31513797

8

Prevention of vascular-allograft rejection by protecting the endothelial glycocalyx with immunosuppressive polymers.

Siren EMJ, Luo HD, Tam F, Montgomery A, Enns W, Moon H, Sim L, Rey K, Guan Q, Wang JJ, Wardell CM, Monajemi M, Mojibian M, Levings MK, Zhang ZJ, Du C, Withers SG, Choy JC, Kizhakkedathu JN. Siren EMJ, et al. Nat Biomed Eng. 2021 Oct;5(10):1202-1216. doi: 10.1038/s41551-021-00777-y. Epub 2021 Aug 9. Nat Biomed Eng. 2021. PMID: 34373602

9

Consequences of adjusting cell density and feed frequency on serum-free expansion of thymic regulatory T cells.

MacDonald KN, Hall MG, Ivison S, Gandhi S, Klein Geltink RI, Piret JM, Levings MK. MacDonald KN, et al. Cytotherapy. 2022 Nov;24(11):1121-1135. doi: 10.1016/j.jcyt.2022.06.006. Epub 2022 Aug 22. Cytotherapy. 2022. PMID: 36008207

10

Innate Control of Tissue-Reparative Human Regulatory T Cells.

Lam AJ, MacDonald KN, Pesenacker AM, Juvet SC, Morishita KA, Bressler B; iGenoMed Consortium; Pan JG, Sidhu SS, Rioux JD, Levings MK. Lam AJ, et al. J Immunol. 2019 Apr 15;202(8):2195-2209. doi: 10.4049/jimmunol.1801330. Epub 2019 Mar 8. J Immunol. 2019. PMID: 30850479

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

18 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year